|
US9611302B2
(en)
|
2007-04-09 |
2017-04-04 |
University Of Florida Research Foundation, Inc. |
High-transduction-efficiency RAAV vectors, compositions, and methods of use
|
|
DK2623605T3
(en)
|
2007-04-09 |
2019-03-25 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
US9725485B2
(en)
*
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
EP2910637A1
(en)
|
2008-05-20 |
2015-08-26 |
University of Florida Research Foundation, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
US11512326B2
(en)
|
2009-05-26 |
2022-11-29 |
University Of Florida Research Foundation, Incorporated |
Small angiotensin peptide expression system in mammalian cells
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
DK3693025T3
(da)
|
2011-04-22 |
2022-01-10 |
Univ California |
Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
|
|
US10294281B2
(en)
|
2012-05-15 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
High-transduction-efficiency rAAV vectors, compositions, and methods of use
|
|
US12358954B2
(en)
|
2012-05-15 |
2025-07-15 |
University Of Florida Research Foundation, Incorporated |
Capsid-modified rAAV vector compositions and methods therefor
|
|
US10981961B2
(en)
|
2013-03-11 |
2021-04-20 |
University Of Florida Research Foundation, Incorporated |
Delivery of card protein as therapy for occular inflammation
|
|
KR102298579B1
(ko)
*
|
2013-05-21 |
2021-09-07 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도
|
|
US11136557B2
(en)
|
2013-05-31 |
2021-10-05 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
EP3049527A4
(en)
|
2013-09-26 |
2017-08-16 |
University of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
|
GB201403684D0
(en)
*
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
WO2015126972A1
(en)
*
|
2014-02-21 |
2015-08-27 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
|
EP3113787B1
(en)
*
|
2014-03-04 |
2019-12-04 |
University of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
|
EP4050020A1
(en)
*
|
2014-03-11 |
2022-08-31 |
University of Florida Research Foundation, Inc. |
Aav-expressed m013 protein as an anti-inflammatroy therapeutic for use in a method of treating inflammatory ocular disease
|
|
US10307492B2
(en)
*
|
2014-03-11 |
2019-06-04 |
Wayne State University |
Modified MGLUR6 promoter and methods of use
|
|
ES2822551T3
(es)
|
2014-03-17 |
2021-05-04 |
Adverum Biotechnologies Inc |
Composiciones y métodos para la expresión génica mejorada en células de los conos
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
EP3215191B1
(en)
|
2014-11-05 |
2024-08-14 |
Voyager Therapeutics, Inc. |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
CN114717264A
(zh)
|
2014-11-14 |
2022-07-08 |
沃雅戈治疗公司 |
治疗肌萎缩性侧索硬化(als)的组合物和方法
|
|
KR20230145206A
(ko)
|
2014-11-14 |
2023-10-17 |
보이저 테라퓨틱스, 인크. |
조절성 폴리뉴클레오티드
|
|
US11759530B2
(en)
*
|
2014-11-17 |
2023-09-19 |
City Of Hope |
TKI permeability enhancers
|
|
EP3221456B1
(en)
*
|
2014-11-21 |
2021-09-22 |
University of Florida Research Foundation, Inc. |
Genome-modified recombinant adeno-associated virus vectors
|
|
US11697825B2
(en)
|
2014-12-12 |
2023-07-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scAAV
|
|
WO2016126857A1
(en)
*
|
2015-02-03 |
2016-08-11 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
|
EP3256170B1
(en)
|
2015-02-13 |
2020-09-23 |
University of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
US10648000B2
(en)
|
2015-02-16 |
2020-05-12 |
University Of Florida Research Foundation, Incorporated |
rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
|
|
WO2016134338A1
(en)
*
|
2015-02-19 |
2016-08-25 |
University Of Florida Research Foundation, Inc. |
Recombinant aav vectors for gene therapy of human hematopoietic disorders
|
|
FI3265178T3
(fi)
|
2015-03-02 |
2026-08-03 |
Adverum Biotechnologies Inc |
Koostumuksia ja menetelmiä polynukleotidien viemiseksi intravitreaalisesti retinaalisiin tappisoluihin
|
|
JP6836999B2
(ja)
*
|
2015-03-24 |
2021-03-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
アデノ随伴ウイルス変異体及びその使用方法
|
|
GB201508026D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
US11266748B2
(en)
*
|
2015-07-02 |
2022-03-08 |
University Of Florida Research Foundation, Incorporated |
Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma
|
|
US20190000943A1
(en)
*
|
2015-08-13 |
2019-01-03 |
Aavet Therapeutics, Llc |
Aav6 vectors for immunotherapy
|
|
IL314171A
(en)
*
|
2015-09-28 |
2024-09-01 |
Univ Florida |
Methods and compositions for antibody-evading virus vectors
|
|
WO2017066764A2
(en)
|
2015-10-16 |
2017-04-20 |
William Marsh Rice University |
Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
|
|
WO2017070476A2
(en)
|
2015-10-22 |
2017-04-27 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav3 capsid library
|
|
AU2016362477A1
(en)
|
2015-12-02 |
2018-06-14 |
Voyager Therapeutics, Inc. |
Assays for the detection of AAV neutralizing antibodies
|
|
CA3011939A1
(en)
*
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
IL297576B2
(en)
|
2016-05-18 |
2024-02-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
|
US10584337B2
(en)
|
2016-05-18 |
2020-03-10 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
CN109640949B
(zh)
|
2016-07-29 |
2022-11-25 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体和其使用方法
|
|
CA3033125A1
(en)
*
|
2016-08-16 |
2018-02-22 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
CA3034089A1
(en)
*
|
2016-08-18 |
2018-02-22 |
The Regents Of The University Of California |
Crispr-cas genome engineering via a modular aav delivery system
|
|
EP3831281B1
(en)
|
2016-08-30 |
2026-02-25 |
The Regents of The University of California |
Devices and systems for biomedical targeting and delivery
|
|
US10650621B1
(en)
|
2016-09-13 |
2020-05-12 |
Iocurrents, Inc. |
Interfacing with a vehicular controller area network
|
|
US11078238B2
(en)
*
|
2016-09-29 |
2021-08-03 |
University Of Florida Research Foundation, Incorporated |
AAVrh.10 variants with host antibody escape capabilities and altered tissue targeting properties
|
|
AU2017345470B2
(en)
|
2016-10-19 |
2023-08-03 |
Adverum Biotechnologies, Inc. |
Modified AAV capsids and uses thereof
|
|
US10633689B2
(en)
*
|
2016-11-07 |
2020-04-28 |
Spark Therapeutics, Inc. |
Rab Escort Protein potency assay
|
|
EP3585883A4
(en)
|
2017-02-21 |
2021-04-14 |
University of Florida Research Foundation, Incorporated |
MODIFIED AAV CAPSID PROTEINS AND USES THEREOF
|
|
MX2019013172A
(es)
|
2017-05-05 |
2020-09-07 |
Voyager Therapeutics Inc |
Composiciones y metodos para tratar la enfermedad de huntington.
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
BR112019023303A2
(pt)
*
|
2017-05-11 |
2020-06-16 |
The Trustees Of The University Of Pennsylvania |
Terapia de gene para lipofuscinoses ceroides neuronais
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
KR20250023600A
(ko)
|
2017-06-30 |
2025-02-18 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법
|
|
CA3070087A1
(en)
|
2017-07-17 |
2019-01-24 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
MX2020001997A
(es)
|
2017-08-28 |
2020-07-20 |
Univ California |
Variantes de capside de virus adenoasociado y metodos de uso de estas.
|
|
MX2020003042A
(es)
|
2017-09-29 |
2020-11-18 |
Voyager Therapeutics Inc |
Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
|
|
TW202413649A
(zh)
|
2017-10-16 |
2024-04-01 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
US12201657B2
(en)
*
|
2017-10-18 |
2025-01-21 |
City Of Hope |
Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof
|
|
JP7385282B2
(ja)
*
|
2017-11-07 |
2023-11-22 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
環状rna分子のための方法及び組成物
|
|
US10806802B2
(en)
*
|
2018-01-18 |
2020-10-20 |
University Of Guelph |
Adeno-associated virus particle with mutated capsid and methods of use thereof
|
|
WO2019152841A1
(en)
|
2018-02-01 |
2019-08-08 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for pah gene transfer and methods of use thereof
|
|
AU2019215152A1
(en)
|
2018-02-01 |
2020-08-20 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof
|
|
US11306329B2
(en)
|
2018-02-19 |
2022-04-19 |
City Of Hope |
Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
|
|
CA3095179A1
(en)
|
2018-04-03 |
2019-10-10 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
BR112020020266A2
(pt)
|
2018-04-03 |
2021-01-19 |
Stridebio, Inc. |
Vetores de vírus com evasão de anticorpos
|
|
MX2020010465A
(es)
*
|
2018-04-03 |
2021-01-08 |
|
Vectores de virus para direccionamiento a tejidos oftalmicos.
|
|
US20210363192A1
(en)
*
|
2018-04-27 |
2021-11-25 |
Spark Therapeutics, Inc. |
Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using same
|
|
WO2019213668A1
(en)
*
|
2018-05-04 |
2019-11-07 |
Oregon Health & Science University |
Human anti-aav2 capsid polyclonal antibody epitopes
|
|
TW202005978A
(zh)
|
2018-05-14 |
2020-02-01 |
美商拜奧馬林製藥公司 |
新穎肝靶向腺相關病毒載體
|
|
WO2019221992A1
(en)
|
2018-05-15 |
2019-11-21 |
President And Fellows Of Harvard College |
Viral vectors exhibiting improved gene delivery properties
|
|
CN112424359A
(zh)
|
2018-05-15 |
2021-02-26 |
沃雅戈治疗公司 |
用于治疗帕金森氏病的组合物和方法
|
|
US11821009B2
(en)
*
|
2018-05-15 |
2023-11-21 |
Cornell University |
Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
|
|
CN112639110A
(zh)
|
2018-06-22 |
2021-04-09 |
阿斯克肋匹奥生物制药公司 |
用于基因递送以在细胞内持续存在的载体
|
|
MX2021001850A
(es)
|
2018-08-18 |
2021-07-15 |
Harvard College |
Edicion genica in situ.
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
AU2019354296A1
(en)
|
2018-10-01 |
2021-04-29 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating propionic acidemia
|
|
WO2020180951A1
(en)
*
|
2019-03-04 |
2020-09-10 |
Adverum Biotechnologies, Inc. |
Sequential intravitreal administration of aav gene therapy to contralateral eyes
|
|
CN113727992A
(zh)
|
2019-03-21 |
2021-11-30 |
斯特里迪比奥公司 |
重组腺相关病毒载体
|
|
US20230038502A1
(en)
*
|
2019-06-11 |
2023-02-09 |
Shire Human Genetic Therapies, Inc. |
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein
|
|
CN114269352A
(zh)
*
|
2019-06-27 |
2022-04-01 |
佛罗里达大学研究基金会 |
用透明质酸增强aav介导的眼组织转导
|
|
EP4010357A2
(en)
|
2019-08-09 |
2022-06-15 |
University of Florida Research Foundation, Incorporated |
Aav capsid variants for targeting human glioblastoma cells
|
|
US20220325296A1
(en)
*
|
2019-09-12 |
2022-10-13 |
The Broad Institute, Inc. |
Engineered adeno-associated virus capsids
|
|
WO2021067598A1
(en)
|
2019-10-04 |
2021-04-08 |
Ultragenyx Pharmaceutical Inc. |
Methods for improved therapeutic use of recombinant aav
|
|
JP2022551986A
(ja)
|
2019-10-16 |
2022-12-14 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
修飾筋肉標的化組成物
|
|
CN114787180A
(zh)
|
2019-10-17 |
2022-07-22 |
斯特里迪比奥公司 |
用于治疗c型尼曼-匹克病的腺相关病毒载体
|
|
MX2022004353A
(es)
|
2019-10-17 |
2022-07-19 |
|
Casete de transferencia de aav.
|
|
CN110724673B
(zh)
*
|
2019-10-31 |
2021-08-06 |
上海爱尔眼科医院有限公司 |
嗜外层视网膜的腺相关病毒病毒体及其应用
|
|
EP4055030A4
(en)
*
|
2019-11-08 |
2024-05-22 |
President And Fellows Of Harvard College |
VIRAL CAPSID POLYPEPTIDES
|
|
EP4055034A4
(en)
|
2019-11-08 |
2024-05-29 |
President And Fellows Of Harvard College |
VIRAL CAPSID POLYPEPTIDES
|
|
WO2021108467A1
(en)
|
2019-11-25 |
2021-06-03 |
University Of Florida Research Foundation, Incorporated |
Novel aav3b variants that target human hepatocytes and evade the humoral immune response
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
FI4103214T3
(fi)
|
2020-02-13 |
2026-07-03 |
Tenaya Therapeutics Inc |
Geeniterapian vektorit sydänsairauden hoitoon
|
|
AU2021218703A1
(en)
|
2020-02-14 |
2022-07-28 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating CDKL5 deficiency disorder
|
|
US20230235353A1
(en)
|
2020-03-19 |
2023-07-27 |
Ultragenyx Pharmaceutical Inc. |
Compositions and methods for reducing reverse packaging of cap and rep sequences in recombinant aav
|
|
US12686874B2
(en)
|
2020-03-31 |
2026-07-21 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating propionic acidemia
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復pah基因功能的腺相關病毒組成物及其使用方法
|
|
US12668814B2
(en)
|
2020-07-22 |
2026-06-30 |
The Broad Institute, Inc. |
Engineered muscle targeting compositions
|
|
JP2023542614A
(ja)
|
2020-08-19 |
2023-10-11 |
サレプタ セラピューティクス, インコーポレイテッド |
レット症候群の治療のためのアデノ随伴ウイルスベクター
|
|
CN112226461B
(zh)
*
|
2020-08-21 |
2022-04-22 |
华侨大学 |
Cd4阳性细胞特异性基因传递载体及其应用
|
|
CA3206107A1
(en)
|
2021-01-26 |
2022-08-04 |
Brian Furmanski |
Vector constructs for delivery of nucleic acids encoding therapeutic anti-tnf antibodies and methods of using the same
|
|
WO2022192708A1
(en)
*
|
2021-03-11 |
2022-09-15 |
Temple University- Of The Commonwealth System Of Higher Education |
Noninvasive aav vectors for highly efficient gene delivery to the nervous system
|
|
JP2024515626A
(ja)
|
2021-04-16 |
2024-04-10 |
アスクレピオス バイオファーマシューティカル, インコーポレイテッド |
血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドaavビリオン
|
|
TW202317768A
(zh)
|
2021-07-08 |
2023-05-01 |
美商特納亞治療股份有限公司 |
用於基因療法的優化表現卡匣
|
|
JP2024531138A
(ja)
|
2021-08-11 |
2024-08-29 |
ウルトラジェニックス ファーマシューティカル インコーポレイテッド |
筋ジストロフィーを処置するための組成物および方法
|
|
CN118201947B
(zh)
*
|
2021-10-28 |
2025-03-21 |
上海天泽云泰生物医药有限公司 |
腺相关病毒衣壳
|
|
US20250277235A1
(en)
*
|
2021-11-30 |
2025-09-04 |
Glugenetherapeutics Inc. |
Mutant of adeno-associated virus capsid protein
|
|
US20250099619A1
(en)
*
|
2021-12-06 |
2025-03-27 |
Juntendo Educational Foundation |
Modified adeno-associated virus vector
|
|
CN116554278A
(zh)
*
|
2022-01-30 |
2023-08-08 |
上海玮美基因科技有限责任公司 |
变异型腺相关病毒及其在疾病治疗中的应用
|
|
CA3245327A1
(en)
|
2022-03-07 |
2023-09-14 |
Ultragenyx Pharmaceutical Inc. |
MODIFIED BATCH-BASED AAV PRODUCTION SYSTEMS AND PROCESSES
|
|
CN116970648A
(zh)
*
|
2022-04-24 |
2023-10-31 |
上海朗昇生物科技有限公司 |
新型aav衣壳改造株及其用途
|
|
EP4536253A1
(en)
*
|
2022-06-08 |
2025-04-16 |
Mesoblast International Sàrl |
Mesenchymal progenitor cells for enhancing partial reprogramming of target cells
|
|
WO2024054864A1
(en)
|
2022-09-06 |
2024-03-14 |
Tenaya Therapeutics, Inc. |
Cardioprotective heart disease therapies
|
|
KR20250142340A
(ko)
|
2023-02-02 |
2025-09-30 |
퀘세라 리미티드 |
재조합 아데노-부속 바이러스 벡터
|
|
WO2024215655A1
(en)
|
2023-04-10 |
2024-10-17 |
Tenaya Therapeutics, Inc. |
Cardioprotective bag3 therapies
|
|
EP4695396A1
(en)
|
2023-04-10 |
2026-02-18 |
Tenaya Therapeutics, Inc. |
Guide rnas, vectors, and virions for targeting mutations in the pln gene
|
|
EP4702151A1
(en)
*
|
2023-04-28 |
2026-03-04 |
Logicbio Therapeutics, Inc. |
Manufacturing and use of recombinant self-complementary aav vectors
|
|
EP4516805A1
(en)
|
2023-09-04 |
2025-03-05 |
Medizinische Hochschule Hannover |
Viral vector for fibroblast transfection
|
|
WO2025090858A1
(en)
|
2023-10-27 |
2025-05-01 |
Biogen Ma Inc. |
Methods for identifying aav capsid variants with desired characteristics
|
|
CN117624311B
(zh)
*
|
2023-11-29 |
2024-05-28 |
广州译码基因科技有限公司 |
可提高aav病毒神经靶向性的衣壳蛋白突变体及其应用
|
|
KR20250137866A
(ko)
|
2024-03-12 |
2025-09-19 |
주식회사 다올이든 |
염증성 피부질환의 치료용 마이크로니들 패치
|
|
WO2026024045A1
(ko)
*
|
2024-07-22 |
2026-01-29 |
한국생명공학연구원 |
변이체 캡시드를 포함하는 아데노-연관 바이러스 및 이의 용도
|
|
WO2026084101A1
(ko)
*
|
2024-10-18 |
2026-04-23 |
주식회사 아바타테라퓨틱스 |
아데노연관바이러스 변이체
|